Increasingly severe air pollution is causing more deadly lung cancers which make lung cancer treatment a top priority. In precision medicine, genomic testing can detect common EGFR, ALK mutations and rare ROS1 mutation, to find the right treatment at the right time. To search for more effective lung cancer treatment strategies, Taiwan Clinical Oncology Society conducts Taiwan Lung Cancer Oncologists meeting and invites ACT Genomics to introduce Next Generation Sequencing and our advantages in genomic testing.